Carrick Therapeutics

About

Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.

Dublin,Dublin,Ireland
51 - 100
http://www.carricktherapeutics.com/

Highlights

Details

Last Funding Type: Series C
Last Funding Money Raised: $60M
Industries: Biotechnology,Health Care,Pharmaceutical,Therapeutics
Founded date: Jan 1, 2015
Number Of Employee: 51 - 100
Operating Status: Active
Legal Name: Carrick Therapeutics Limited

Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated. The company's therapeutics target molecular pathways that drive the most aggressive and resistant forms of cancer using innovative mechanisms, enabling cancer patients to get their predictive biomarkers detected and get their treatments started from early stage.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

2

$155M

Carrick Therapeutics has raised a total of $155M in funding over 2 rounds. Their latest funding was raised on Dec 1, 2022 from a Series C round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 1, 2022	Series C	$60M	7	Pfizer	—	Detail
Oct 3, 2016	Series A	$95M	7	ARCH Venture Partners Woodford Investment Management	—	Detail

Investors

Number of Lead Investors

Number of Investors

3

9

Carrick Therapeutics is funded by 9 investors. Pfizer and Woodford Investment Management are the most recent investors.

Investor Name	Lead Investor	Funding Round
Pfizer	Yes	Series C
Woodford Investment Management	Yes	Series A
Evotec	—	Series C
ARCH Venture Partners	—	Series C
Cambridge Innovation Capital	—	Series C
GV	—	Series C
Lightstone Ventures	—	Series C
Rosetta Capital	—	Series C
University of Cambridge Enterprise	—	Series A